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 HIGHLIGHTS  
 Fusion proteins is a suitable strategy for recombinant production of proteins in the soluble 
form. 
 NusA fusion tag improves the solubility of recombinant proteins expressed in bacterial 
hosts. 









Recombinant production  
 
 Insulin-Like Growth Factor-1 (IGF-1) is a small peptide with 70 amino acids and 
7.6 kDa molecular weight that acts as the major mediator of growth hormone. 
According to the previous studies, recombinant production of human IGF-1 
(rhIGF-1) in E. coli has resulted in an inactive form of protein (inclusion body). 
There are several strategies to transform inclusion body to a soluble form. 
Production in the form of fusion proteins as a suitable strategy, helps researcher 
in recombinant production of proteins in the soluble and active form. In current 
study, NusA fusion protein was used to produce IGF-1 soluble form, instead of 
insoluble protein. In previous study, rhIGF-1 was optimally expressed in 
inclusion body with 1.2 g/L concentration. rhIGF1 -NusA construct was cloned 
and expressed in E. coli, then, cell lysate was analyze by SDS-PAGE and 
densitometry techniques, to assay soluble and insoluble form of rhIGF-1. Results 
showed that rhIGF-1 concentration in soluble phase was 0.14 g/L, indicating that 
about 12% of total expression of rhIGF-1 was in the soluble form through NusA-
fusion protein strategy. These results confirmed that some fusion proteins like 
NusA could improve the solubility of recombinant proteins expressed in 
heterogeneous bacterial hosts.  
 
Introduction  
Insulin-Like Growth Factor-1 (IGF-1) is secreted by 
different tissues and plays a critical role in metabolism 
and growth. Recombinant IGF-1 consists of 70 amino 
acids and two disulfide bond. E. coli is a routine 
organism for the commercially production of rhIGF-1 
that has some advantages and disadvantages compared 
to eukaryotic host (Ranjbari, 2019; Ranjbari et al., 
2015). One of the most important disadvantages of 
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production of proteins in the form of insoluble and 
inactive inclusion bodies (Babaeipour et al., 2018).  
When a foreign recombinant protein is expressed in  
E. coli, the new microenvironment is different from that 
of the original source in terms of pH, osmolarity, redox 
potential, cofactors, and folding mechanisms. Also, high 
level expression under a powerful promoter results in 
high concentrations of hydrophobic assemblies of 
polypeptides. All of these factors lead to protein 
aggregation and formation of inclusion body (Carrio and 
Villaverde, 2002; Rosano and Ceccarelli, 2014). 
Another reason for the formation of insoluble form of 
recombinant protein in E. coli is the formation of 
incorrect disulfide bonds. Correct formation of disulfide 
bonds are important in the proper three-dimensional 
conformation and biological activity of recombinant 
protein (Messens and Collet, 2006; Lobstein et al., 
2012). In E. coli, oxido-reductase system is in the 
periplasmic area, where the cysteine oxidation takes 
place and disulfide bonds are formed. Hence, disulfide 
bonds formation in the cytoplasmic area is very weak 
and in incorrect form, therefore, results in the protein 
misfolding (Derman et al., 1993; Messens and Collet, 
2006).  
Directing the protein to the periplasm, using the 
engineered strains with oxidative cytoplasmic 
environment, cultivation in lower temperature than 
optimal, tuning inducer concentration and fusing the 
recombinant protein to a solubility enhancer like fusion 
partners are useful strategies to increase recombinant 
protein solubility (Rosano and Ceccarelli, 2014). 
Thioredoxin, maltose-binding protein, glutathione S-
transferase, ubiquitin, Small ubiquitin-like modifier 
protein (SUMO) and N-utilization substance protein A 
(NusA) are the most usual fusion partners in biology. 
The exact effect of fusion partners as solubility 
enhancers has not been understood, however, several 
hypothesis have been proposed (Raran-Kurussi and 
Waugh, 2012).  
In the case of NusA, it was shown that it increases 
the solubility of foreign proteins. Usually, E. coli NusA 
protein promotes hairpin folding and tagging the N-
terminal of insoluble proteins with NusA makes them 
soluble through expression in E. coli. Also, NusA can 
combined with the His-tag that is useful for purification 
process (Harrison, 2000; Terpe, 2003). 
 
Materials and Methods 
 
Strain and vector  
 
Origami (B/DE3) was approved as an appropriate strain 
of E. coli for rhIGF-1 production. The protein of rhIGF-
1 has two disulfide bonds in its structure. Origami 
(B/DE3) strain with mutation in thioredoxin reductase 
(trxB) and glutathione reductase (gor) genes, provides a 
suitable microenvironment for the proper formation of 
disulfide bond. pET-44a and pET-15b plasmids 
(Novagen), ampicillin resistant plasmids, were used as 
vector in this study (Fig. 1). pET-44a consists of a NusA 
tag with 495 amino acids. Synthetic rhIGF-1 gene was 
cloned in pET-44a plasmid (NusA fused) and pET15b 
(without fusion tag) under control of strong 
bacteriophage T7 promoter (Fig. 1).  
 
         
 
 









According to our previous study, an optimized culture 
condition included 32y culture medium, 32°C culture 
temperature and 0.05 Mm inducer (IPTG).32y culture 
medium composition was: peptone 0.8 %( w/v), yeast 
extract 3.2% (w/v), NaCl 0.58 (w/v) in Tris-HCl 10 mM 
(pH=7.6) (Ranjbari et al., 2015). 
 
Transformation and expression of rhIGF-1 
 
Both rhIGF1- pET44a and rhIGF1-pET15b constructs 
were transformed into Origami (B/DE3) strain by 
Calcium chloride transformation technique. 
Transformed colonies were grown in 32y culture 
medium containing 100 μg/ml ampicillin. Also, protein 
expression was induced by 0.05 mM IPTG. Samples 
were collected up to 8h after induction. 
 
Western blot analysis of rhIGF-1 
 
Western blot technique was used for rhIGF1-NusA 
fusion complex identification. Collected samples after 
induction were lysed and cell lysate was analyzed by the 
SDS-PAGE 12.5%, 2 h at 100 V, along with molecular 
weight markers (Sigma). For Western blotting, proteins 
resolved by SDS-PAGE were electrophoretically 
transferred to a nitrocellulose membrane (Wathman, 
UK). Phosphate buffered saline with 5% nonfat milk 
was used for blocking the membrane. The membrane 
immersed in 1:2000 dilution of peroxidase-conjugated 
anti IGF-1 monoclonal antibody (Abcam, UK) for 2 h at 
room temperature. Subsequently, it was visualized after 
color development by chromogenic substrate 3, 3’-




In order to quantification of SDS-PAGE data, we used 
Bradford and densitometry (image J software) 
techniques. Optical density is the result of darkness of a 
developed picture and can be expressed absolutely as 
the number of dark spots in a given area, but usually it 
is a relative value, expressed in a scale. Densitometry is 
particularly useful due to its sensitivity, accuracy and 
versatility, and it can be applied to proteins in gels or on 
membranes. In addition to being accurate, sensitive and 
reproducible, the technique is cost-effective, simple, and 
does not require a high degree of specialized training, 
yet provides technical advantages over other available 
tool. The rhIGF-1expression level was determined by 
SDS-PAGE 12.5% (w/v). Gels were stained with 
Coomassie brilliant blue G250 and then, quantified by 
gel densitometer. Bradford protein assay was used for 
the quantitative analysis of total protein with standard 
protocol (Taylor et al., 2013). 
 
Results and Discussion 
 
Nowadays, proteins are widely produced in Escherichia 
coli, as promising cell factories. The aggregation of 
exogenous proteins into insoluble inclusion bodies is 
one of the main limiting factors of the E. coli expression 
system. Protein fusion technology has been widely used 
for the enhanced production of soluble protein in E. coli 
(Costa et al., 2014). Fusion protein tag of NusA has 
identified as a highly soluble protein when expressed in 
E. coli. NusA may be a very good tag protein for 
solubilizing of large recombinant proteins. Tyrosinase, 
hIFN-γ, Growth Hormone (GH), hIL-3 are good 
example of NusA fused protein with an efficient 
production soluble form (Harrison, 2000). 
 
Transformation and expression of IGF1 without fusion tag 
 
DNA sequence encoding human IGF-1 was cloned in 
pET15b. pET15b-rhIGF1 construct containing the 
rhIGF-1 gene sequence confirmed by automated DNA 
sequencing. The expression plasmid was then 
transformed into E. coli strain Origami (B/DE3). In the 
presence of 0.05 mM IPTG, the expression of the 
protein was induced. Six hours after induction, 
transformed cells were analyzed for rhIGF1-NusA 
expression by SDS-PAGE (Fig. 2). Results showed that 
rhIGF-1 was produced completely (1.6 mg/ml) as 
insoluble inclusion body without coproduction of NusA. 
 
 
Figure 2. SDS-PAGE 17.5% gel analysis of rhIGF-1 expression in E. 
coli. M: Molecular weight marker, lane 1: soluble phase protein 
expression pattern, lane 2: insoluble phase protein expression pattern. 
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Table 1. IGF-1 concentration in soluble and insoluble form. 



















(mg/ml) (mg/ml)  (mg/ml) (mg/ml) (mg/ml)  (mg/ml)  (mg/ml)  (mg/ml) 
 5.33 1.6 1.6 0 4 1.2 1.06 0.14 
 
Effect of NusA fusion protein on rhIGF-1 solubility 
 
DNA sequence encoding human IGF-1 was cloned in 
pET44a. pET44a-rhIGF1 construct containing the  
rhIGF-1 – NusA gene sequence confirmed by automated 
DNA sequencing. The expression plasmid was then 
transformed into E. coli strain Origami (B/DE3). In the 
presence of 0.05 mM IPTG, the expression of the protein 
was induced. To assess the effect of NusA fusion protein 
on rhIGF-1 solubility, cultures were harvested 6h post 
induction, the cell pellets were lysed by sonication, and 
the lysates were centrifuged and separated into soluble 
and insoluble fractions. The proteins in both fractions 
were analyzed by SDS-PAGE 12% followed by 
Coomassie G-250 staining. Fusion of NusA to the  
rhIGF-1 protein resulted in the enhanced solubility of 
rhIGF-1, and approximately 12% (0.14 mg/ml) of  
rhIGF-1 was produced in soluble form (Fig. 3) (Table1). 
 
 
Figure 3. SDS-PAGE 12% gel analysis of rhIGF1-NusA expression in 
E. coli. M: Molecular weight marker, lane 1: soluble phase protein 
expression pattern, lane 2: insoluble phase protein expression pattern. 
 
Western blot analysis of rhIGF-1 
 
rhIGF1-NusA expression was also analyzed by Western 
blotting using anti-human IGF-1 antibody (Abcam-USA) 
for further identification (Fig. 4). According to Fig. 3, 
Western blotting analysis approved production of 
rhIGF1- NusA complex. 
Conclusion 
 
Ease of manipulation, short doubling time, high cell 
density and cost benefit of production make E. coli one 
of the most widely used host systems for recombinant 
protein production. RhIGF-1 as a heterogeneous protein 
had expressed in E. coli in the form of inclusion body. 
Aggregated proteins in inclusion bodies have not proper 
folding and complete biological activity. Nowadays, 
various strategies are applied to increase the production 
of recombinant heterogeneous proteins in soluble form. 
Optimized inducer concentration, periplasmic 
expression, use of strains with oxidative cytoplasmic 
environment, cultivation at lower temperature and the 
fusion of recombinant protein to a solubility enhancer 
partners are usual methods to increase recombinant 
protein solubility. In this study, we used NusA fusion 
protein to increase the soluble form of rhIGF-1 through 
recombinant production in E. coli. According to the 
results, NusA could change rhIGF-1 aggregate form 
towards the soluble form. Therefore, this fusion partner 
is a promising tag for increasing the soluble form of 
rhIGF-1 protein in lab or industrial scale.  
 
 
Figure 4. Western blot analysis of NusA fused rhIGF1 
expression in E. coli. M: Molecular weight marker, lane 1: 
Western blot analysis of IGF1-NusA expression after 
induction, lane 2: Western blot analysis of IGF1-NusA 
expression before induction. 
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